TrialInvestigational new drugs2012

A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors.

Aung Naing et al.PubMed ↗Publisher ↗

No numbers read from the abstract.